bf/AMEX:LCTX_icon.png

COM:LINEAGECELL

Lineage Cell Therapeutics, Inc.

  • Stock

Last Close

0.60

22/11 21:00

Market Cap

115.05M

Beta: -

Volume Today

15.56M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-52.91M
-
-43.78M
17.26%
-58.13M
32.79%
18.62M
132.03%
-23.29M
225.07%
-46.78M
100.88%
-11.83M
74.72%
-20.68M
74.90%
-43.27M
109.19%
-26.35M
39.10%
-21.49M
18.47%
depreciation and amortization
3.95M
-
8.41M
112.79%
6.33M
24.69%
4.76M
24.90%
3.30M
30.71%
3.27M
0.70%
3M
8.34%
2.04M
32.03%
873K
57.18%
727K
16.72%
692K
4.81%
deferred income tax
-3.28M
-
-7.38M
124.82%
-4.52M
38.77%
-4.52M
0%
-17.57M
289.15%
-346K
98.03%
-7.41M
2,040.75%
-1.24M
83.27%
-6.00M
383.86%
-1.80M
-
stock based compensation
3.22M
-
4.46M
38.46%
11.05M
148.01%
7.95M
28.05%
3.93M
50.55%
5.40M
37.39%
3.58M
33.73%
2.23M
37.79%
3.52M
58.02%
4.29M
21.82%
4.64M
8.23%
change in working capital
2.73M
-
-827.05K
130.34%
3.31M
499.61%
-741K
122.42%
2.48M
434.41%
638K
74.25%
-1.96M
406.58%
1.37M
170.19%
21.11M
1,437.51%
18.67M
11.56%
-10.80M
157.87%
accounts receivables
-180.93K
-
-73.78K
59.22%
-248K
236.12%
-39K
84.27%
-172K
341.03%
46K
126.74%
467K
915.22%
287K
38.54%
-857K
398.61%
50.31M
5,970.95%
-446K
100.89%
inventory
-123.38K
-
-87.33K
29.22%
-75K
14.12%
-75K
0%
1.30M
1,836%
122K
90.63%
2.88M
2,264.75%
-308K
110.68%
-72K
76.62%
accounts payables
2.13M
-
-469.75K
122.02%
1.67M
456.14%
12K
99.28%
1.30M
10,725%
1.10M
15.32%
-2.88M
362.27%
308K
110.68%
21.64M
6,927.60%
-18.70M
186.40%
-2.29M
87.73%
other working capital
896.67K
-
-196.18K
121.88%
1.96M
1,096.52%
-639K
132.69%
49K
107.67%
-630K
1,385.71%
-2.42M
284.60%
1.09M
144.82%
394K
63.72%
-12.94M
3,385.03%
-8.06M
37.70%
other non cash items
16.79M
-
261.80K
98.44%
-2.58M
1,086.63%
-68.40M
2,548.01%
640K
100.94%
6.93M
983.59%
-17.34M
349.99%
-3.47M
80.00%
202K
105.82%
3.73M
1,746.04%
195K
94.77%
net cash provided by operating activities
-29.51M
-
-38.85M
31.67%
-44.54M
14.64%
-42.33M
4.98%
-30.52M
27.90%
-30.88M
1.20%
-31.95M
3.45%
-19.75M
38.17%
-23.56M
19.28%
1.06M
104.49%
-28.57M
2,797.45%
investments in property plant and equipment
-2.28M
-
-483.10K
78.79%
-5.33M
1,004.13%
-2.53M
52.64%
-1.33M
47.51%
-3.29M
147.89%
-440K
86.61%
-64K
85.45%
-354K
453.13%
-413K
16.67%
-674K
63.20%
acquisitions net
-8.38M
-
-8.90M
6.23%
15.11M
269.82%
17.33M
14.70%
13.06M
24.64%
10.09M
22.79%
45.75M
353.60%
674.00K
98.53%
purchases of investments
-1.25M
-
-748K
40.06%
-189K
74.73%
-14.21M
-
4.56M
132.08%
6.02M
32.11%
-53.41M
986.65%
-16.40M
69.29%
sales maturities of investments
748K
-
14.21M
-
-4.56M
132.08%
-6.02M
32.11%
7.67M
227.26%
63.53M
728.67%
other investing activites
-1.39M
-
-524.71K
62.21%
-859K
63.71%
13K
101.51%
188K
1,346.15%
-8K
104.26%
65K
912.50%
41K
36.92%
14K
65.85%
-45.75M
326,857.14%
-674K
98.53%
net cash used for investing activites
-3.67M
-
-1.01M
72.51%
-7.44M
638.34%
-10.89M
46.34%
-10.22M
6.10%
11.82M
215.56%
16.96M
43.51%
13.04M
23.11%
9.74M
25.26%
-46.16M
573.67%
46.45M
200.63%
debt repayment
-26.21K
-
-59K
125.10%
-145K
145.76%
-253K
74.48%
-349K
37.94%
-100K
71.35%
-26K
74%
-20K
23.08%
-32K
60%
-54K
68.75%
common stock issued
35.04M
-
44.62M
27.35%
49.11M
10.07%
30.85M
37.19%
59.68M
93.47%
6M
89.95%
103K
98.28%
5.13M
4,877.67%
30.86M
502.01%
148K
99.52%
6.51M
4,301.35%
common stock repurchased
-888K
-
-241K
72.86%
-110K
54.36%
-27K
75.45%
-54K
100%
-17K
68.52%
-37K
117.65%
dividends paid
-454K
-
-34.41M
7,479.07%
-40K
99.88%
-25.15M
62,767.50%
-7.24M
71.21%
-37K
-
other financing activites
-772.20K
-
19.03M
2,564.56%
15.72M
17.37%
2.08M
86.77%
-2.69M
229.36%
34.77M
1,391.72%
764K
97.80%
49.94M
6,436.39%
13.38M
73.21%
1.53M
88.54%
37K
97.59%
net cash used provided by financing activities
34.26M
-
63.62M
85.69%
64.78M
1.81%
32.78M
49.39%
55.39M
68.97%
5.77M
89.58%
617K
89.31%
29.86M
4,740.36%
36.93M
23.66%
1.63M
95.58%
6.42M
293.57%
effect of forex changes on cash
56.10K
-
230.19K
310.30%
-48K
120.85%
292K
708.33%
101K
65.41%
6K
94.06%
70K
1,066.67%
-63K
190%
-20K
68.25%
-873K
4,265%
-250K
71.36%
net change in cash
1.15M
-
23.99M
1,994.39%
12.74M
46.89%
-20.14M
258.07%
14.75M
173.23%
-13.29M
190.07%
-14.30M
7.65%
23.09M
261.41%
23.09M
0.03%
-44.34M
292.00%
24.09M
154.32%
cash at beginning of period
4.35M
-
5.50M
26.33%
29.49M
436.57%
42.23M
43.21%
22.09M
47.69%
37.69M
70.61%
24.40M
35.26%
10.10M
58.62%
33.18M
228.67%
56.28M
69.60%
11.36M
79.82%
cash at end of period
5.50M
-
29.49M
436.57%
42.23M
43.21%
22.09M
47.69%
36.84M
66.78%
24.40M
33.77%
10.10M
58.62%
33.18M
228.67%
56.28M
69.60%
11.94M
78.79%
35.44M
196.93%
operating cash flow
-29.51M
-
-38.85M
31.67%
-44.54M
14.64%
-42.33M
4.98%
-30.52M
27.90%
-30.88M
1.20%
-31.95M
3.45%
-19.75M
38.17%
-23.56M
19.28%
1.06M
104.49%
-28.57M
2,797.45%
capital expenditure
-2.28M
-
-483.10K
78.79%
-5.33M
1,004.13%
-2.53M
52.64%
-1.33M
47.51%
-3.29M
147.89%
-440K
86.61%
-64K
85.45%
-354K
453.13%
-413K
16.67%
-674K
63.20%
free cash flow
-31.79M
-
-39.34M
23.76%
-49.88M
26.80%
-44.85M
10.08%
-31.84M
29.00%
-34.17M
7.30%
-32.39M
5.22%
-19.82M
38.81%
-23.91M
20.68%
646K
102.70%
-29.24M
4,626.32%

All numbers in (except ratios and percentages)